Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Supply, Demand and Key Producers, 2024-2030

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Supply, Demand and Key Producers, 2024-2030

Page: 108

Published Date: 01 Mar 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.

This report studies the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for PET Radioisotope (Radiopharmaceuticals in PET Imaging), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of PET Radioisotope (Radiopharmaceuticals in PET Imaging) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) total production and demand, 2019-2030, (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) total production value, 2019-2030, (USD Million)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) domestic production, consumption, key domestic manufacturers and share
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).

This reports profiles key players in the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Blue Earth Diagnostics, ANSTO and ROSATOM, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PET Radioisotope (Radiopharmaceuticals in PET Imaging) market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market, Segmentation by Type
11C
13N
150
18F
Others

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market, Segmentation by Application
Medical Imaging
Scientific Research

Companies Profiled:
IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM

Key Questions Answered
1. How big is the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
2. What is the demand of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
3. What is the year over year growth of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
4. What is the production and production value of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
5. Who are the key producers in the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
btl

Table of Contents

1 Supply Summary
1.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Introduction
1.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Supply & Forecast
1.2.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019 & 2023 & 2030)
1.2.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.2.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Pricing Trends (2019-2030)
1.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (Based on Production Site)
1.3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2019-2030)
1.3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2019-2030)
1.3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2019-2030)
1.3.4 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.3.5 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.3.6 China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.3.7 Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Major Market Trends

2 Demand Summary
2.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Demand (2019-2030)
2.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region
2.2.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2024)
2.2.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Forecast by Region (2025-2030)
2.3 United States PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.4 China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.5 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.6 Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.7 South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.8 ASEAN PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.9 India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)

3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers Competitive Analysis
3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Manufacturer (2019-2024)
3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Manufacturer (2019-2024)
3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturer (2019-2024)
3.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) in 2023
3.5.3 Global Concentration Ratios (CR8) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) in 2023
3.6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Overall Company Footprint Analysis
3.6.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Region Footprint
3.6.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Type Footprint
3.6.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Comparison
4.1.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison
4.2.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Comparison
4.3.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers and Market Share, 2019-2024
4.4.1 United States Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019-2024)
4.4.3 United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024)
4.5 China Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers and Market Share
4.5.1 China Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019-2024)
4.5.3 China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024)
4.6 Rest of World Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024)

5 Market Analysis by Type
5.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 11C
5.2.2 13N
5.2.3 150
5.2.4 18F
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2019-2030)
5.3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2019-2030)
5.3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Medical Imaging
6.2.2 Scientific Research
6.3 Market Segment by Application
6.3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2019-2030)
6.3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2019-2030)
6.3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2030)

7 Company Profiles
7.1 IBA Molecular
7.1.1 IBA Molecular Details
7.1.2 IBA Molecular Major Business
7.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.1.4 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 IBA Molecular Recent Developments/Updates
7.1.6 IBA Molecular Competitive Strengths & Weaknesses
7.2 GE Healthcare
7.2.1 GE Healthcare Details
7.2.2 GE Healthcare Major Business
7.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.2.4 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 GE Healthcare Recent Developments/Updates
7.2.6 GE Healthcare Competitive Strengths & Weaknesses
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Details
7.3.2 Siemens Healthineers Major Business
7.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.3.4 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Siemens Healthineers Recent Developments/Updates
7.3.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Details
7.4.2 Eli Lilly and Company Major Business
7.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.4.4 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Eli Lilly and Company Recent Developments/Updates
7.4.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.5 Mallinckrodt Pharmaceuticals
7.5.1 Mallinckrodt Pharmaceuticals Details
7.5.2 Mallinckrodt Pharmaceuticals Major Business
7.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.5.4 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.5.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Blue Earth Diagnostics
7.6.1 Blue Earth Diagnostics Details
7.6.2 Blue Earth Diagnostics Major Business
7.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.6.4 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Blue Earth Diagnostics Recent Developments/Updates
7.6.6 Blue Earth Diagnostics Competitive Strengths & Weaknesses
7.7 ANSTO
7.7.1 ANSTO Details
7.7.2 ANSTO Major Business
7.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.7.4 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 ANSTO Recent Developments/Updates
7.7.6 ANSTO Competitive Strengths & Weaknesses
7.8 ROSATOM
7.8.1 ROSATOM Details
7.8.2 ROSATOM Major Business
7.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.8.4 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 ROSATOM Recent Developments/Updates
7.8.6 ROSATOM Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Chain
8.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Upstream Analysis
8.2.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Core Raw Materials
8.2.2 Main Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Mode
8.6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Procurement Model
8.7 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Sales Model and Sales Channels
8.7.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Model
8.7.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2019-2024) & (USD Million)
Table 3. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2025-2030) & (USD Million)
Table 4. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2019-2024)
Table 5. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2025-2030)
Table 6. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2019-2024) & (Tons)
Table 7. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2025-2030) & (Tons)
Table 8. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2019-2024)
Table 9. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2025-2030)
Table 10. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2019-2024) & (US$/Ton)
Table 11. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2025-2030) & (US$/Ton)
Table 12. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Major Market Trends
Table 13. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Tons)
Table 14. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2024) & (Tons)
Table 15. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Forecast by Region (2025-2030) & (Tons)
Table 16. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producers in 2023
Table 18. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Manufacturer (2019-2024) & (Tons)
Table 19. Production Market Share of Key PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producers in 2023
Table 20. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Evaluation Quadrant
Table 22. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Site of Key Manufacturer
Table 24. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Type Footprint
Table 25. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Application Footprint
Table 26. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Competitive Factors
Table 27. PET Radioisotope (Radiopharmaceuticals in PET Imaging) New Entrant and Capacity Expansion Plans
Table 28. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Mergers & Acquisitions Activity
Table 29. United States VS China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison, (2019 & 2023 & 2030) & (Tons)
Table 31. United States VS China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Comparison, (2019 & 2023 & 2030) & (Tons)
Table 32. United States Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024) & (Tons)
Table 36. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share (2019-2024)
Table 37. China Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024) & (Tons)
Table 41. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share (2019-2024)
Table 42. Rest of World Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024) & (Tons)
Table 46. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share (2019-2024)
Table 47. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2019-2024) & (Tons)
Table 49. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2025-2030) & (Tons)
Table 50. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2019-2024) & (USD Million)
Table 51. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2025-2030) & (USD Million)
Table 52. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2024) & (US$/Ton)
Table 53. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2025-2030) & (US$/Ton)
Table 54. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2019-2024) & (Tons)
Table 56. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2025-2030) & (Tons)
Table 57. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2019-2024) & (USD Million)
Table 58. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2025-2030) & (USD Million)
Table 59. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2024) & (US$/Ton)
Table 60. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2025-2030) & (US$/Ton)
Table 61. IBA Molecular Basic Information, Manufacturing Base and Competitors
Table 62. IBA Molecular Major Business
Table 63. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 64. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. IBA Molecular Recent Developments/Updates
Table 66. IBA Molecular Competitive Strengths & Weaknesses
Table 67. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. GE Healthcare Major Business
Table 69. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 70. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. GE Healthcare Recent Developments/Updates
Table 72. GE Healthcare Competitive Strengths & Weaknesses
Table 73. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 74. Siemens Healthineers Major Business
Table 75. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 76. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Siemens Healthineers Recent Developments/Updates
Table 78. Siemens Healthineers Competitive Strengths & Weaknesses
Table 79. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 80. Eli Lilly and Company Major Business
Table 81. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 82. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Eli Lilly and Company Recent Developments/Updates
Table 84. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 85. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Mallinckrodt Pharmaceuticals Major Business
Table 87. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 88. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 90. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
Table 92. Blue Earth Diagnostics Major Business
Table 93. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 94. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Blue Earth Diagnostics Recent Developments/Updates
Table 96. Blue Earth Diagnostics Competitive Strengths & Weaknesses
Table 97. ANSTO Basic Information, Manufacturing Base and Competitors
Table 98. ANSTO Major Business
Table 99. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 100. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. ANSTO Recent Developments/Updates
Table 102. ROSATOM Basic Information, Manufacturing Base and Competitors
Table 103. ROSATOM Major Business
Table 104. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 105. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 106. Global Key Players of PET Radioisotope (Radiopharmaceuticals in PET Imaging) Upstream (Raw Materials)
Table 107. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Customers
Table 108. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Distributors
List of Figure
Figure 1. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Picture
Figure 2. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 5. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price (2019-2030) & (US$/Ton)
Figure 6. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2019-2030)
Figure 7. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2019-2030)
Figure 8. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 9. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 10. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 11. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 12. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 15. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Region (2019-2030)
Figure 16. United States PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 17. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 18. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 19. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 20. South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 21. ASEAN PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 22. India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 23. Producer Shipments of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) Markets in 2023
Figure 26. United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share 2023
Figure 30. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share 2023
Figure 31. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share 2023
Figure 32. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type in 2023
Figure 34. 11C
Figure 35. 13N
Figure 36. 150
Figure 37. 18F
Figure 38. Others
Figure 39. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2019-2030)
Figure 40. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type (2019-2030)
Figure 41. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2030) & (US$/Ton)
Figure 42. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application in 2023
Figure 44. Medical Imaging
Figure 45. Scientific Research
Figure 46. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2019-2030)
Figure 47. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application (2019-2030)
Figure 48. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2030) & (US$/Ton)
Figure 49. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Chain
Figure 50. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Procurement Model
Figure 51. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Model
Figure 52. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Supply, Demand and Key Producers, 2024-2030

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Supply, Demand and Key Producers, 2024-2030

Page: 108

Published Date: 01 Mar 2024

Category: Chemical & Material

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

PET (Positron Emission Tomography) radioisotopes, also known as radiopharmaceuticals, are compounds containing radioactive isotopes that emit positrons. These radioisotopes are used in PET imaging to visualize and quantify biological processes within the body.

This report studies the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for PET Radioisotope (Radiopharmaceuticals in PET Imaging), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of PET Radioisotope (Radiopharmaceuticals in PET Imaging) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) total production and demand, 2019-2030, (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) total production value, 2019-2030, (USD Million)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) domestic production, consumption, key domestic manufacturers and share
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).

This reports profiles key players in the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include IBA Molecular, GE Healthcare, Siemens Healthineers, Eli Lilly and Company, Mallinckrodt Pharmaceuticals, Blue Earth Diagnostics, ANSTO and ROSATOM, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World PET Radioisotope (Radiopharmaceuticals in PET Imaging) market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Ton) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market, Segmentation by Type
11C
13N
150
18F
Others

Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market, Segmentation by Application
Medical Imaging
Scientific Research

Companies Profiled:
IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM

Key Questions Answered
1. How big is the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
2. What is the demand of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
3. What is the year over year growth of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
4. What is the production and production value of the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
5. Who are the key producers in the global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market?
btl

Table of Contents

1 Supply Summary
1.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Introduction
1.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Supply & Forecast
1.2.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019 & 2023 & 2030)
1.2.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.2.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Pricing Trends (2019-2030)
1.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (Based on Production Site)
1.3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2019-2030)
1.3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2019-2030)
1.3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2019-2030)
1.3.4 North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.3.5 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.3.6 China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.3.7 Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Major Market Trends

2 Demand Summary
2.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Demand (2019-2030)
2.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region
2.2.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2024)
2.2.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Forecast by Region (2025-2030)
2.3 United States PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.4 China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.5 Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.6 Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.7 South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.8 ASEAN PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)
2.9 India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030)

3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers Competitive Analysis
3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Manufacturer (2019-2024)
3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Manufacturer (2019-2024)
3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturer (2019-2024)
3.4 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) in 2023
3.5.3 Global Concentration Ratios (CR8) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) in 2023
3.6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Overall Company Footprint Analysis
3.6.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Region Footprint
3.6.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Type Footprint
3.6.3 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Comparison
4.1.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison
4.2.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Comparison
4.3.1 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers and Market Share, 2019-2024
4.4.1 United States Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019-2024)
4.4.3 United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024)
4.5 China Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers and Market Share
4.5.1 China Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019-2024)
4.5.3 China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024)
4.6 Rest of World Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024)

5 Market Analysis by Type
5.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 11C
5.2.2 13N
5.2.3 150
5.2.4 18F
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2019-2030)
5.3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2019-2030)
5.3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Medical Imaging
6.2.2 Scientific Research
6.3 Market Segment by Application
6.3.1 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2019-2030)
6.3.2 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2019-2030)
6.3.3 World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2030)

7 Company Profiles
7.1 IBA Molecular
7.1.1 IBA Molecular Details
7.1.2 IBA Molecular Major Business
7.1.3 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.1.4 IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 IBA Molecular Recent Developments/Updates
7.1.6 IBA Molecular Competitive Strengths & Weaknesses
7.2 GE Healthcare
7.2.1 GE Healthcare Details
7.2.2 GE Healthcare Major Business
7.2.3 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.2.4 GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 GE Healthcare Recent Developments/Updates
7.2.6 GE Healthcare Competitive Strengths & Weaknesses
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Details
7.3.2 Siemens Healthineers Major Business
7.3.3 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.3.4 Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Siemens Healthineers Recent Developments/Updates
7.3.6 Siemens Healthineers Competitive Strengths & Weaknesses
7.4 Eli Lilly and Company
7.4.1 Eli Lilly and Company Details
7.4.2 Eli Lilly and Company Major Business
7.4.3 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.4.4 Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Eli Lilly and Company Recent Developments/Updates
7.4.6 Eli Lilly and Company Competitive Strengths & Weaknesses
7.5 Mallinckrodt Pharmaceuticals
7.5.1 Mallinckrodt Pharmaceuticals Details
7.5.2 Mallinckrodt Pharmaceuticals Major Business
7.5.3 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.5.4 Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.5.6 Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Blue Earth Diagnostics
7.6.1 Blue Earth Diagnostics Details
7.6.2 Blue Earth Diagnostics Major Business
7.6.3 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.6.4 Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Blue Earth Diagnostics Recent Developments/Updates
7.6.6 Blue Earth Diagnostics Competitive Strengths & Weaknesses
7.7 ANSTO
7.7.1 ANSTO Details
7.7.2 ANSTO Major Business
7.7.3 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.7.4 ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 ANSTO Recent Developments/Updates
7.7.6 ANSTO Competitive Strengths & Weaknesses
7.8 ROSATOM
7.8.1 ROSATOM Details
7.8.2 ROSATOM Major Business
7.8.3 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
7.8.4 ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 ROSATOM Recent Developments/Updates
7.8.6 ROSATOM Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Chain
8.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Upstream Analysis
8.2.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Core Raw Materials
8.2.2 Main Manufacturers of PET Radioisotope (Radiopharmaceuticals in PET Imaging) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Mode
8.6 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Procurement Model
8.7 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Sales Model and Sales Channels
8.7.1 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Model
8.7.2 PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2019-2024) & (USD Million)
Table 3. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Region (2025-2030) & (USD Million)
Table 4. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2019-2024)
Table 5. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2025-2030)
Table 6. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2019-2024) & (Tons)
Table 7. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Region (2025-2030) & (Tons)
Table 8. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2019-2024)
Table 9. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2025-2030)
Table 10. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2019-2024) & (US$/Ton)
Table 11. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Region (2025-2030) & (US$/Ton)
Table 12. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Major Market Trends
Table 13. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Tons)
Table 14. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption by Region (2019-2024) & (Tons)
Table 15. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Forecast by Region (2025-2030) & (Tons)
Table 16. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producers in 2023
Table 18. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Manufacturer (2019-2024) & (Tons)
Table 19. Production Market Share of Key PET Radioisotope (Radiopharmaceuticals in PET Imaging) Producers in 2023
Table 20. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Manufacturer (2019-2024) & (US$/Ton)
Table 21. Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Company Evaluation Quadrant
Table 22. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Site of Key Manufacturer
Table 24. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Type Footprint
Table 25. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market: Company Product Application Footprint
Table 26. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Competitive Factors
Table 27. PET Radioisotope (Radiopharmaceuticals in PET Imaging) New Entrant and Capacity Expansion Plans
Table 28. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Mergers & Acquisitions Activity
Table 29. United States VS China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Comparison, (2019 & 2023 & 2030) & (Tons)
Table 31. United States VS China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Comparison, (2019 & 2023 & 2030) & (Tons)
Table 32. United States Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024) & (Tons)
Table 36. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share (2019-2024)
Table 37. China Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024) & (Tons)
Table 41. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share (2019-2024)
Table 42. Rest of World Based PET Radioisotope (Radiopharmaceuticals in PET Imaging) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2024) & (Tons)
Table 46. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share (2019-2024)
Table 47. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2019-2024) & (Tons)
Table 49. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Type (2025-2030) & (Tons)
Table 50. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2019-2024) & (USD Million)
Table 51. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type (2025-2030) & (USD Million)
Table 52. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2024) & (US$/Ton)
Table 53. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2025-2030) & (US$/Ton)
Table 54. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2019-2024) & (Tons)
Table 56. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production by Application (2025-2030) & (Tons)
Table 57. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2019-2024) & (USD Million)
Table 58. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application (2025-2030) & (USD Million)
Table 59. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2024) & (US$/Ton)
Table 60. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2025-2030) & (US$/Ton)
Table 61. IBA Molecular Basic Information, Manufacturing Base and Competitors
Table 62. IBA Molecular Major Business
Table 63. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 64. IBA Molecular PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. IBA Molecular Recent Developments/Updates
Table 66. IBA Molecular Competitive Strengths & Weaknesses
Table 67. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 68. GE Healthcare Major Business
Table 69. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 70. GE Healthcare PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. GE Healthcare Recent Developments/Updates
Table 72. GE Healthcare Competitive Strengths & Weaknesses
Table 73. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 74. Siemens Healthineers Major Business
Table 75. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 76. Siemens Healthineers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Siemens Healthineers Recent Developments/Updates
Table 78. Siemens Healthineers Competitive Strengths & Weaknesses
Table 79. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 80. Eli Lilly and Company Major Business
Table 81. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 82. Eli Lilly and Company PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Eli Lilly and Company Recent Developments/Updates
Table 84. Eli Lilly and Company Competitive Strengths & Weaknesses
Table 85. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 86. Mallinckrodt Pharmaceuticals Major Business
Table 87. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 88. Mallinckrodt Pharmaceuticals PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Mallinckrodt Pharmaceuticals Recent Developments/Updates
Table 90. Mallinckrodt Pharmaceuticals Competitive Strengths & Weaknesses
Table 91. Blue Earth Diagnostics Basic Information, Manufacturing Base and Competitors
Table 92. Blue Earth Diagnostics Major Business
Table 93. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 94. Blue Earth Diagnostics PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Blue Earth Diagnostics Recent Developments/Updates
Table 96. Blue Earth Diagnostics Competitive Strengths & Weaknesses
Table 97. ANSTO Basic Information, Manufacturing Base and Competitors
Table 98. ANSTO Major Business
Table 99. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 100. ANSTO PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. ANSTO Recent Developments/Updates
Table 102. ROSATOM Basic Information, Manufacturing Base and Competitors
Table 103. ROSATOM Major Business
Table 104. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Product and Services
Table 105. ROSATOM PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (Tons), Price (US$/Ton), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 106. Global Key Players of PET Radioisotope (Radiopharmaceuticals in PET Imaging) Upstream (Raw Materials)
Table 107. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Customers
Table 108. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Typical Distributors
List of Figure
Figure 1. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Picture
Figure 2. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 5. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price (2019-2030) & (US$/Ton)
Figure 6. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Region (2019-2030)
Figure 7. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Region (2019-2030)
Figure 8. North America PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 9. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 10. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 11. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production (2019-2030) & (Tons)
Figure 12. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 15. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share by Region (2019-2030)
Figure 16. United States PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 17. China PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 18. Europe PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 19. Japan PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 20. South Korea PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 21. ASEAN PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 22. India PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption (2019-2030) & (Tons)
Figure 23. Producer Shipments of PET Radioisotope (Radiopharmaceuticals in PET Imaging) by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for PET Radioisotope (Radiopharmaceuticals in PET Imaging) Markets in 2023
Figure 26. United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: PET Radioisotope (Radiopharmaceuticals in PET Imaging) Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share 2023
Figure 30. China Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share 2023
Figure 31. Rest of World Based Manufacturers PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share 2023
Figure 32. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type in 2023
Figure 34. 11C
Figure 35. 13N
Figure 36. 150
Figure 37. 18F
Figure 38. Others
Figure 39. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Type (2019-2030)
Figure 40. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Type (2019-2030)
Figure 41. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Type (2019-2030) & (US$/Ton)
Figure 42. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 43. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application in 2023
Figure 44. Medical Imaging
Figure 45. Scientific Research
Figure 46. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Market Share by Application (2019-2030)
Figure 47. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Production Value Market Share by Application (2019-2030)
Figure 48. World PET Radioisotope (Radiopharmaceuticals in PET Imaging) Average Price by Application (2019-2030) & (US$/Ton)
Figure 49. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Industry Chain
Figure 50. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Procurement Model
Figure 51. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Model
Figure 52. PET Radioisotope (Radiopharmaceuticals in PET Imaging) Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

IBA Molecular
GE Healthcare
Siemens Healthineers
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Blue Earth Diagnostics
ANSTO
ROSATOM
jiaGou

Add To Cart

gouMai

Buy Now